CEACAM5 and gastric cancer: The combination of CEA, CA19-9 and CA72-4 exhibited an improved diagnostic efficacy for GC cases (AUC 0.834; 95% CI = 0.778–0.891; sensitivity: 78.41%; specificity: 96.92%) relative to any individual biomarker (p < 0.05).